Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Moxifloxacin (0.5% w/v) + Difluprednate (0.05% w/v)
Therapeutic Category
Antibiotic, Anti-Inflammatories, ENT
Dosage Form
Ear Drops
Packaging Type
Dropper
Packaging
5ml
Price
₹120/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Moxolunic DF Ear Drop combines the powerful antibiotic Moxifloxacin (0.5%) with the anti-inflammatory corticosteroid Difluprednate (0.05%) to treat ear infections effectively. Moxifloxacin is a broad-spectrum antibiotic that works by inhibiting the bacteria’s ability to replicate, ultimately killing the pathogens responsible for causing infections. Difluprednate, a potent corticosteroid, reduces inflammation, swelling, redness, and discomfort often associated with ear infections. This combination is ideal for treating both the infection and the inflammatory response, providing quick and long-lasting relief.
Moxolunic DF Ear Drop is specially formulated for the treatment of bacterial ear infections and inflammation, including acute otitis externa and otitis media with effusion. It is particularly beneficial in conditions where both infection and inflammation are present, such as in cases of bacterial outer ear infections or middle ear infections with fluid build-up. The dual action of the antibiotic and anti-inflammatory medication in this ear drop helps reduce the discomfort and risk of complications associated with these infections.
The ear drop is easy to use and is absorbed locally, providing direct treatment to the affected area without significant systemic effects. It is an effective solution for both short-term relief and long-term healing when used according to the prescribed regimen.
Possible side effects include temporary irritation, itching, or burning in the ear. Rarely, it may cause allergic reactions or worsen existing ear conditions. Discontinue use if any severe reactions occur and consult your healthcare provider immediately.
Acute otitis externa (outer ear infection) Otitis media with effusion (middle ear infection with fluid) Inflammatory conditions of the ear
Avoid using if you have a perforated eardrum or a fungal ear infection. Consult a doctor before use if pregnant, breastfeeding, or if you have any other ear-related issues.
Store at room temperature, away from moisture and direct sunlight. Keep the bottle tightly closed and out of reach of children.
Composition : Moxifloxacin (0.5% w/v) + Dexamethasone (0.1% w/v)
Composition : Ofloxacin (0.3% w/v) + Ketorolac (0.5% w/v)
Composition : Moxifloxacin (0.5% w/v) + Prednisolone (1% w/v)
Composition : Moxifloxacin (5% w/v) + Betamethasone (0.1% w/v)
Composition : Ofloxacin (0.3% w/v) Eye Ear Drops
Composition : Moxifloxacin (0.5% w/v)
Composition : Dexamethasone (0.1% w/v) + Tobramycin (0.3% w/v)
Composition : Tobramycin (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Moxifloxacin 0.5% w/v + Difluprednate 0.05% w/v Ear Drops have strong demand in the ENT, anti-infective, and specialty healthcare segment, making them a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on ear care and infection management portfolios.
Medical distributors and agencies can benefit from consistent demand for ear infection and inflammation management under medical supervision. Moxifloxacin 0.5% w/v is a broad-spectrum fluoroquinolone antibiotic that helps control susceptible bacterial infections Difluprednate 0.05% w/v is a potent corticosteroid that helps reduce inflammation, swelling, redness, and discomfort Commonly prescribed for bacterial ear infections, inflammatory ear conditions, post-procedural ear care, and ENT-related infections as advised by healthcare professionals The combination helps address both infection and inflammation simultaneously for comprehensive management Ear drop formulation ensures targeted delivery directly to the affected area Widely prescribed by ENT specialists and healthcare professionals This strengthens a comprehensive ENT and anti-infective portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Moxifloxacin 0.5% w/v + Difluprednate 0.05% w/v Ear Drops with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from steady ENT prescription demand, repeat orders, reliable supply chain support, and attractive margins in the specialty ear care and anti-infective segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality product ranges, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.